Drug:
Reaction: DYSPNOEA
20260101 - 20261231
No. 401 - 500
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 401 | 26536961 |
CA |
2 | |
Pneumonia, Lung disorder, Fall, Chest injury, Dyspnoea, Productive cough, |
||||
BENRALIZUMAB, BENRALIZUMAB, ALBUTEROL SULFATE, PREDNISONE, CICLESONIDE, |
||||
| 402 | 26537022 |
US |
73 | 2 |
Neoplasm malignant, Respiratory disorder, Cough, Dyspnoea, Drug ineffective, Injection site pain, Injection site pruritus, |
||||
DUPILUMAB, |
||||
| 403 | 26537064 |
US |
83 | 1 |
Syncope, Heart rate increased, Swelling, Dyspnoea, |
||||
DUPILUMAB, |
||||
| 404 | 26537069 |
US |
72 | 2 |
Dyspnoea, |
||||
DUPILUMAB, ALBUTEROL SULFATE, CALCIUM, ENALAPRIL, MIDODRINE HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, PREDNISONE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, CALCIUM ACETATE, CALCIUM ACETATE CAPSULES 667 MG, |
||||
| 405 | 26537086 |
US |
71 | 2 |
Dyspnoea, |
||||
DUPILUMAB, |
||||
| 406 | 26537109 |
EU |
60 | 2 |
Urticaria, Dyspnoea, |
||||
| 407 | 26537171 |
EU |
7 | 1 |
Oxygen saturation decreased, Dyspnoea, Product dose omission issue, Influenza, Productive cough, Pyrexia, |
||||
IDURSULFASE, IDURSULFASE, IDURSULFASE, IDURSULFASE, |
||||
| 408 | 26537442 |
CN |
34 | 2 |
Laryngeal oedema, Oxygen saturation decreased, Dyspnoea, Cough, Rash erythematous, |
||||
PERTUZUMAB, |
||||
| 409 | 26537465 |
US |
69 | 1 |
Mycobacterial infection, Cardiomyopathy, Bronchiectasis, Nasal congestion, Sputum discoloured, Insomnia, Fatigue, Weight decreased, Vision blurred, Hypoacusis, Rhinorrhoea, Cough, Wheezing, Arthralgia, Rash, Asthenia, Dyspnoea, Productive cough, Asthma prophylaxis, Dysphonia, Tuberculin test positive, Obstructive sleep apnoea syndrome, Infectious disease carrier, Hypertension, Acute sinusitis, Rhinitis allergic, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, TIRZEPATIDE, ALPRAZOLAM, MECLIZINE HCL 12.5 MG, MECLIZINE HCL 25 MG, MECLIZINE HYDROCHLORIDE, MECLIZINE, MECLIZINE HCL 25MG, MECLIZINE HCL 12.5MG, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, BENZONATATE, DICLOFENAC, DICLOFENAC SODIUM, MONTELUKAST, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, DAPAGLIFLOZIN, ZOLPIDEM TARTRATE, IPRATROPIUM BROMIDE, ALBUTEROL SULFATE, |
||||
| 410 | 26537497 |
EU |
77 | 2 |
Dyspnoea, Erythema, Vertigo, Hypersensitivity, Headache, |
||||
PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 411 | 26537663 |
58 | ||
Dyspnoea, Feeling abnormal, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 412 | 26537717 |
US |
60 | 2 |
Oxygen saturation decreased, Pulmonary hypertension, Headache, Oropharyngeal pain, Cough, Dyspnoea, Cyanosis, Weight decreased, Gastrointestinal disorder, Carbon dioxide increased, Walking distance test abnormal, Back pain, Neck pain, Clubbing, Tachycardia, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, NINTEDANIB, ROSUVASTATIN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ACETAMINOPHEN, FLUTICASONE PROPIONATE, PHYTONADIONE, MAGNESIUM, AMLODIPINE BESYLATE, LOPERAMIDE HYDROCHLORIDE, ALBUTEROL SULFATE AND BUDESONIDE, CALCIUM, MONTELUKAST SODIUM, MONTELUKAST, OXYGEN, 0XYGEN, OXYGEN, 0XYGEN, OXYGEN, 0XYGEN, OXYGEN, 0XYGEN, OXYGEN, 0XYGEN, ERGOCALCIFEROL, PROPRANOLOL HYDROCHLORIDE, ALBUTEROL SULFATE, ALBUTEROL, MAGNESIUM HYDROXIDE, POLYETHYLENE GLYCOL 3350, MELATONIN, NALOXONE HYDROCHLORIDE NASAL, NALOXONE HYDROCHLORIDE, POLYETHYLENE GLYCOL 3350, STANDARDIZED SENNA CONCENTRATE AND DOCUSATE SODIUM, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 413 | 26537767 |
US |
1 | |
Weight increased, Dyspnoea, |
||||
FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, AMBRISENTAN, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 414 | 26537797 |
CA |
72 | |
Dyspnoea, Intentional product use issue, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, CALCIUM, PANCRELIPASE, HYDROCORTISONE, DEXLANSOPRAZOLE, FOLIC ACID, ISONIAZID, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, LEVETIRACETAM, OLANZAPINE, OXYCODONE HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE, OXYCODONE, ALBUTEROL SULFATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, DESOXIMETASONE, |
||||
| 415 | 26537804 |
US |
64 | 1 |
Dyspnoea, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 416 | 26537812 |
EU |
12 | 2 |
Arrhythmia, Headache, Nausea, Dyspnoea, Chest pain, Infection, Dizziness, |
||||
| 417 | 26537823 |
EU |
63 | 2 |
Dyspnoea, Oxygen saturation decreased, Flushing, |
||||
PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 418 | 26537828 |
US |
33 | 2 |
Anxiety, Cardiac flutter, Pericardial effusion, Palpitations, Muscle oedema, Pleural effusion, Dyspnoea, Panic attack, Heart rate irregular, Dyspnoea, Asthma, Upper respiratory tract infection, Cough, Nasal congestion, |
||||
ASCIMINIB, |
||||
| 419 | 26537960 |
US |
2 | |
Weight decreased, Anxiety, Arthralgia, Anaphylactic reaction, Dyspnoea, Pruritus, |
||||
OMALIZUMAB, OMALIZUMAB, |
||||
| 420 | 26537967 |
EG |
60 | 1 |
Cough, Dyspnoea, Erythema, |
||||
PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), FAMOTIDINE, FAMOTIDINE, FAMOTIDINE, FAMOTIDINE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXTROSE MONOHYDRATE, DEXTROSE, DEXTROSE MONOHYDRATE, DEXTROSE, DEXTROSE MONOHYDRATE, DEXTROSE, DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
| 421 | 26537989 |
EG |
39 | 2 |
Lung consolidation, Pulmonary mass, Lymphadenopathy mediastinal, Chest discomfort, Chest pain, Hot flush, Dyspnoea, Abdominal pain, Infusion related hypersensitivity reaction, Vomiting, Nausea, |
||||
CARBOPLATIN, CARBOPLATIN, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), TRASTUZUMAB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, FAMOTIDINE, CHLORPHENIRAMINE MALEATE, |
||||
| 422 | 26537991 |
CA |
43 | 2 |
Type 2 diabetes mellitus, Abdominal pain, Abdominal pain upper, Adverse event, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Anxiety, Arthralgia, Arthropathy, Blister, Breast cancer stage III, Chest pain, Condition aggravated, Decreased appetite, Diarrhoea, Disability, Dizziness, Duodenal ulcer perforation, Dyspnoea, Nausea, Pruritus, Osteoarthritis, Pneumonia, Product use issue, Fatigue, Bronchitis, Grip strength decreased, Oedema, Drug hypersensitivity, Seronegative arthritis, Gait disturbance, Intentional product use issue, Insomnia, Adverse drug reaction, Therapeutic product effect incomplete, Amnesia, Therapeutic response decreased, Pyrexia, Treatment failure, Adjustment disorder with depressed mood, Liver function test increased, Muscular weakness, Dislocation of vertebra, Therapeutic product effect decreased, Upper respiratory tract infection, Hepatic enzyme increased, Foot deformity, Sciatica, Spondylitis, Mobility decreased, Oedema peripheral, Musculoskeletal stiffness, Rheumatic fever, Injury, Joint dislocation, Sinusitis, Headache, Swollen joint count increased, Delirium, Visual impairment, Weight decreased, C-reactive protein increased, Hypersensitivity, Osteoporosis, Discomfort, Tachycardia, Hypertension, Contraindicated product administered, Joint range of motion decreased, Drug tolerance decreased, Retinitis, Blood cholesterol increased, Depression, Drug-induced liver injury, Drug ineffective, Vomiting, Helicobacter infection, Hypoaesthesia, Infection, Infusion related reaction, Joint swelling, Live birth, Liver injury, Malaise, Maternal exposure during pregnancy, Memory impairment, Muscle injury, Off label use, Pain, Pemphigus, Pericarditis, Peripheral swelling, Product use in unapproved indication, Psoriasis, Psoriatic arthropathy, Rash, Rheumatoid arthritis, Abdominal discomfort, Walking aid user, Wheezing, Wound, Wound infection, Exposure during pregnancy, Fibromyalgia, General physical health deterioration, Glossodynia, Hand deformity, Prescribed overdose, Rheumatoid factor positive, Sleep disorder, Swelling, Synovitis, Systemic lupus erythematosus, Therapy non-responder, Treatment noncompliance, |
||||
DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, CANDESARTAN, CANDESARTAN, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, OXYCODONE HYDROCHLORIDE, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ERENUMAB-AOOE, ERENUMAB-AOOE, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, CALCIUM CARBONATE, CALCIUM CARBONATE, CALCIUM CARBONATE, CALCIUM CARBONATE, SARILUMAB, PREGABALIN, PREGABALIN, PREDNISONE, TRIPROLIDINE HYDROCHLORIDE, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, CERTOLIZUMAB PEGOL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, OXYCODONE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, VITAMIN C, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, LEFLUNOMIDE, LEFLUNOMIDE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, FOLIC ACID, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, RITUXIMAB, RITUXIMAB, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, ETANERCEPT, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, APREMILAST, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, NAPROXEN, NAPROXEN SODIUM, APREPITANT, APREPITANT, APREPITANT, APREPITANT, APREPITANT, APREPITANT, APREPITANT, APREPITANT, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METHYLPREDNISOLONE SODIUM SUCCINATE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, PREGABALIN, SARILUMAB, APREMILAST, APREMILAST, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, TOFACITINIB, TOFACITINIB, TOFACITINIB, GOLIMUMAB, GOLIMUMAB, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, VEDOLIZUMAB, |
||||
| 423 | 26537997 |
EU |
59 | 2 |
Upper airway obstruction, Obstructive airways disorder, Bronchospasm, Dyspnoea, Off label use, |
||||
GABAPENTIN, |
||||
| 424 | 26538053 |
EG |
67 | 2 |
Laryngeal oedema, Altered state of consciousness, Angioedema, Dyspnoea, |
||||
CISPLATIN, DOCETAXEL, DOCETAXEL ANHYDROUS, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, MAGNESIUM SULFATE, MAGNESIUM SULFATE HEPTAHYDRATE, MAGNESIUM SULFATE IN WATER FOR, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
| 425 | 26538123 |
EU |
67 | 2 |
Oral disorder, Tongue disorder, Nausea, Dyspnoea, |
||||
AMOXICILLIN, LOSARTAN, BISOPROLOL FUMARATE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, AMLODIPINE, QUETIAPINE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, |
||||
| 426 | 26538124 |
GB |
61 | 1 |
Erythema, Rash, Dyspnoea, Vision blurred, Livedo reticularis, |
||||
PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM, PIPERACILLIN AND TAZOBACTAM, PIPERACILLIN SODIUM,TAZOBACTAM SODIUM, |
||||
| 427 | 26538239 |
US |
76 | 2 |
Secretion discharge, Dyspnoea, |
||||
DUPILUMAB, |
||||
| 428 | 26538334 |
US |
86 | 1 |
Dyspnoea, Mobility decreased, Pericardial effusion, |
||||
NINTEDANIB, |
||||
| 429 | 26538344 |
US |
2 | |
Palpitations, Dyspnoea, Product delivery mechanism issue, Product dose omission issue, |
||||
TIOTROPIUM BROMIDE INHALATION SPRAY, |
||||
| 430 | 26538407 |
US |
68 | 1 |
Malignant neoplasm progression, Neuropathy peripheral, Vocal cord paralysis, Haemoptysis, General physical condition abnormal, White blood cell count increased, Decreased appetite, Blood alkaline phosphatase increased, Blood sodium decreased, Blood chloride decreased, Fatigue, Dysphonia, Cough, Arthralgia, Myalgia, Weight decreased, Haemoglobin decreased, Haematocrit decreased, Blood glucose increased, Seborrhoeic dermatitis, Pruritus, Normocytic anaemia, Hypertension, Oedema, Off label use, Drug intolerance, Oedema peripheral, Erythema, Confusional state, Dysphonia, Respiratory disorder, Gastrooesophageal reflux disease, Nausea, Vomiting, Hypoglycaemia, Visual impairment, Dyspnoea, Dyspnoea, |
||||
OLAPARIB, OLAPARIB, NICOTINE POLACRILEX, |
||||
| 431 | 26538476 |
US |
73 | 2 |
Cough, Dyspnoea, |
||||
POMALIDOMIDE, |
||||
| 432 | 26538621 |
AU |
1 | 1 |
Dyspnoea, Decreased eye contact, Speech disorder developmental, Behaviour disorder, |
||||
| 433 | 26538647 |
US |
2 | |
Pneumonia, Bronchospasm, Dyspnoea at rest, Dyspnoea exertional, Weight decreased, General physical health deterioration, Decreased activity, Dyspnoea, Cough, Depression, Drug ineffective, |
||||
ENSIFENTRINE, ENSIFENTRINE, ENSIFENTRINE, ENSIFENTRINE, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, LEVALBUTEROL, LEVALBUTEROL HYDROCHLORIDE, BUDESONIDE, REVEFENACIN, SELEXIPAG, ROFLUMILAST, ROSUVASTATIN, EZETIMIBE, PREDNISONE, MONTELUKAST, DUPILUMAB, |
||||
| 434 | 26538702 |
US |
33 | 2 |
Thyroid cancer, Dyspnoea, Fatigue, Thyroid disorder, Malaise, Swelling, Hypotension, Injection site irritation, Device issue, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TADALAFIL, POTASSIUM BICARBONATE, FUROSEMIDE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE, ESOMEPRAZOLE MAGNESIUM DIHYDRATE, ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES, SILDENAFIL CITRATE, SILDENAFIL, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, IRON, OXYGEN, 0XYGEN, ESCITALOPRAM, ONDANSETRON HYDROCHLORIDE, |
||||
| 435 | 26538731 |
69 | 2 | |
Dyspnoea, |
||||
MEPOLIZUMAB, |
||||
| 436 | 26538765 |
US |
6 | 1 |
Cystic fibrosis respiratory infection suppression, Pneumonia, Autism spectrum disorder, Dyspnoea, Weight decreased, Bacterial infection, Cough, Pulmonary function test decreased, Vomiting, Hypophagia, Ear infection, Sinusitis, |
||||
ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR, DUPILUMAB, DUPILUMAB, DORNASE ALFA, |
||||
| 437 | 26538788 |
US |
82 | 2 |
Dyspnoea, |
||||
DUPILUMAB, |
||||
| 438 | 26538809 |
EU |
43 | 2 |
Palpitations, Dyspnoea, Throat tightness, |
||||
BOTULINUM TOXIN TYPE A, |
||||
| 439 | 26538867 |
EU |
65 | 2 |
Ventricular dysfunction, Dyspnoea, |
||||
TRASTUZUMAB, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, PERTUZUMAB, |
||||
| 440 | 26538885 |
US |
1 | |
Respiratory depression, Dyspnoea, |
||||
ENSIFENTRINE, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, ALBUTEROL SULFATE, |
||||
| 441 | 26538925 |
TW |
50 | 1 |
Dyspnoea, Cardiac failure, Pancreatitis acute, Diabetes mellitus inadequate control, Dyspnoea, Abdominal pain, Abdominal pain, Abdominal pain upper, Abdominal distension, |
||||
FENOFIBRATE, SEMAGLUTIDE, SEMAGLUTIDE, REPAGLINIDE, EMPAGLIFLOZIN AND LINAGLIPTIN, PENTOXIFYLLINE, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, BISOPROLOL FUMARATE, EDOXABAN TOSYLATE, SACUBITRIL AND VALSARTAN, FUROSEMIDE, ROSUVASTATIN, |
||||
| 442 | 26538965 |
US |
2 | |
Multiple fractures, Dyspnoea, |
||||
DUPILUMAB, |
||||
| 443 | 26538989 |
EG |
68 | 2 |
Dyspnoea, Normochromic normocytic anaemia, Leukopenia, Neutropenia, |
||||
CARBOPLATIN, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, |
||||
| 444 | 26539147 |
US |
44 | 2 |
Dyspnoea, |
||||
DUPILUMAB, |
||||
| 445 | 26539266 |
US |
1 | |
Pneumonia, Oxygen consumption increased, Exercise tolerance decreased, Productive cough, Dyspnoea, |
||||
TREPROSTINIL, TREPROSTINIL, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, MACITENTAN, WARFARIN SODIUM, WARFARIN, KETAMINE HYDROCHLORIDE, EPLERENONE, CLONIDINE, KETOPROFEN, SILDENAFIL CITRATE, LIDOCAINE HYDROCHLORIDE, LIDOCAINE HYDROCHLORIDE ANHYDROUS, DIGOXIN, AMITRIPTYLINE HYDROCHLORIDE, GABAPENTIN, |
||||
| 446 | 26539276 |
US |
43 | 1 |
Catheterisation venous, Dyspnoea, Sleep disorder, |
||||
NIPOCALIMAB, |
||||
| 447 | 26539302 |
CA |
2 | |
Pneumonia, Wheezing, Dyspnoea, |
||||
ALBUTEROL SULFATE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, TIOTROPIUM BROMIDE INHALATION SPRAY, |
||||
| 448 | 26539333 |
US |
60 | 1 |
Dyspnoea, Wrong technique in product usage process, Device delivery system issue, |
||||
BUDESONIDE AND FORMOTEROL FUMARATE, |
||||
| 449 | 26539340 |
CO |
2 | |
Respiratory distress, Urticaria, Dyspnoea, |
||||
DUPILUMAB, |
||||
| 450 | 26539345 |
GB |
38 | 2 |
Pulmonary pain, Swelling of nose, Sinus pain, Sinus headache, Constipation, Dyspnoea, Headache, |
||||
GABAPENTIN, BISOPROLOL FUMARATE, |
||||
| 451 | 26539346 |
US |
2 | |
Urticaria, Dyspnoea, Amnesia, Peripheral swelling, Dry mouth, Malaise, Headache, |
||||
MONTELUKAST SODIUM, MONTELUKAST, |
||||
| 452 | 26539382 |
US |
1 | |
Atrial fibrillation, Fatigue, Weight increased, Dyspnoea, Insomnia, |
||||
SEMAGLUTIDE, |
||||
| 453 | 26539486 |
US |
81 | 2 |
Hospitalisation, Dyspnoea, Gait disturbance, Product storage error, |
||||
INSULIN GLARGINE, |
||||
| 454 | 26539495 |
US |
||
Pyrexia, Cough, Oxygen saturation increased, Dyspnoea exertional, Dizziness postural, Chest pain, Dyspnoea, Dizziness, Cough, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, OXYGEN, 0XYGEN, |
||||
| 455 | 26539522 |
JP |
18 | 1 |
Pulmonary mass, Pulmonary cavitation, Off label use, White blood cell count decreased, Drug ineffective for unapproved indication, Dyspnoea, Pyrexia, Haemoglobin decreased, |
||||
FILGRASTIM, FILGRASTIM, RITUXIMAB, METHYLPREDNISOLONE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, HYDROXYCHLOROQUINE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, AZATHIOPRINE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, SULFAMETHOXAZOLE AND TRIMETHOPRIM, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MEROPENEM, AMPHOTERICIN B, ITRACONAZOLE, |
||||
| 456 | 26539662 |
CO |
49 | 2 |
Respiratory arrest, Chest pain, Dyspnoea, |
||||
OSIMERTINIB, |
||||
| 457 | 26539671 |
US |
67 | 1 |
Dyspnoea, |
||||
MAVACAMTEN, HYDROCHLOROTHIAZIDE, EMPAGLIFLOZIN, ATORVASTATIN CALCIUM, LISINOPRIL, DULAGLUTIDE, |
||||
| 458 | 26539695 |
US |
75 | 2 |
Cough, Sneezing, Nausea, Dyspnoea, |
||||
ACOLTREMON, NAPROXEN SODIUM, NAPROXEN SODIUM TABLET, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, ALENDRONATE SODIUM, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, EMPAGLIFLOZIN, LORAZEPAM, SPIRONOLACTONE, VITAMIN C, ERGOCALCIFEROL, |
||||
| 459 | 26539803 |
US |
84 | 2 |
Dizziness, Dyspnoea, Condition aggravated, Treatment noncompliance, |
||||
ACOLTREMON, ACYCLOVIR, LOSARTAN, LOTEPREDNOL ETABONATE, PREDNISONE, POLYVINYL ALCOHOL, POVIDONE, CYCLOSPORINE OPHTHALMIC SOLUTION, |
||||
| 460 | 26539940 |
US |
69 | 2 |
Dyspnoea, Blood pressure increased, Hot flush, Blood glucose decreased, Peripheral coldness, |
||||
DUPILUMAB, |
||||
| 461 | 26540015 |
EU |
36 | 2 |
Cough, Pruritus, Dyspnoea, |
||||
TRAMADOL HYDROCHLORIDE, |
||||
| 462 | 26540053 |
US |
||
Diarrhoea, Dyspnoea, |
||||
ACORAMIDIS HYDROCHLORIDE, |
||||
| 463 | 26540165 |
US |
59 | 1 |
Dyspnoea, Haemoglobin decreased, Fatigue, |
||||
BELZUTIFAN, TIVOZANIB, |
||||
| 464 | 26540179 |
60 | 1 | |
Dysphoria, Pallor, Gastrointestinal disorder, Anaphylactic shock, Blood pressure decreased, Dizziness, Abdominal pain, Chest discomfort, Dyspnoea, Rash, Nausea, Pruritus, |
||||
SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 465 | 26540387 |
BR |
48 | 2 |
Chest pain, Dyspnoea, Malaise, Pruritus, Hyperaemia, Tachypnoea, Abdominal pain upper, Dizziness, Nausea, Vision blurred, Vomiting, Hypotension, Pyrexia, Infusion site reaction, |
||||
| 466 | 26540600 |
CA |
39 | 2 |
Chest pain, Dyspnoea, |
||||
TRANEXAMIC ACID, |
||||
| 467 | 26540773 |
US |
84 | 2 |
Dyspnoea, |
||||
ACOLTREMON, ACYCLOVIR, SULFAMETHOXAZOLE AND TRIMETHOPRIM, LOSARTAN, LOTEPREDNOL ETABONATE, PREDNISONE, CYCLOSPORINE OPHTHALMIC SOLUTION, |
||||
| 468 | 26541006 |
US |
60 | 1 |
Dyspnoea, Asthma, |
||||
DUPILUMAB, |
||||
| 469 | 26541061 |
US |
88 | 2 |
Oedema peripheral, Dysphonia, Rhinorrhoea, Insomnia, Dyspnoea, Vision blurred, Abdominal distension, Pollakiuria, Diarrhoea, Pruritus, Erythema, Rash, Blepharitis, |
||||
DUPILUMAB, RIVAROXABAN, DIGOXIN, TERAZOSIN, TERAZOSIN HYDROCHLORIDE, AMLODIPINE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, SPIRONOLACTONE, FUROSEMIDE, |
||||
| 470 | 26541137 |
US |
46 | 1 |
Nephrolithiasis, Pharyngitis streptococcal, Intervertebral disc degeneration, Cough, Dyspnoea, |
||||
SPARSENTAN, |
||||
| 471 | 26541205 |
US |
2 | |
Dyspnoea, |
||||
| 472 | 26541226 |
CA |
1 | |
Hypoglycaemia, Dyspnoea, |
||||
CLOZAPINE, |
||||
| 473 | 26541235 |
EU |
69 | 2 |
Pulmonary toxicity, Dyspnoea, Diabetes mellitus, Secretion discharge, Musculoskeletal discomfort, Epistaxis, Bone pain, Dizziness, |
||||
MORPHINE SULFATE, ABEMACICLIB, HYDROCORTISONE, LETROZOLE, LETROZOLE TABLETS, |
||||
| 474 | 26541283 |
GB |
47 | 1 |
Botulism, Off label use, Neuromuscular blockade, Eyelid ptosis, Hyporeflexia, Hypotonia, Muscular weakness, Stridor, Dyspnoea, Dysphonia, Diplopia, Bulbar palsy, Pneumonia, Dysphagia, Vocal cord paralysis, Respiratory failure, Respiratory distress, |
||||
LETIBOTULINUMTOXINA-WLBG, |
||||
| 475 | 26541286 |
GB |
35 | 2 |
Botulism, Off label use, Fatigue, Diplopia, Hyporeflexia, Fatigue, Uvula deviation, Trigeminal nerve disorder, Dysphonia, Tongue movement disturbance, Hyperaesthesia, Dry mouth, Dysphonia, Eyelid ptosis, Intentional product misuse, Dysphonia, Facial paresis, Dyspnoea, Dysphagia, |
||||
LETIBOTULINUMTOXINA-WLBG, |
||||
| 476 | 26541321 |
CN |
61 | 1 |
Urticaria, Chest discomfort, Flushing, Sinus tachycardia, Dyspnoea, |
||||
RAMUCIRUMAB, |
||||
| 477 | 26541335 |
42 | 1 | |
Palpitations, Dyspnoea, Chest discomfort, Pruritus, |
||||
CETUXIMAB, |
||||
| 478 | 26541487 |
US |
65 | 2 |
Pharyngeal swelling, Dyspnoea, |
||||
ACOLTREMON, INSULIN ASPART, |
||||
| 479 | 26541532 |
CA |
75 | 1 |
Asthma, Cardiac failure congestive, Chronic obstructive pulmonary disease, Dyspnoea, Full blood count abnormal, Lung disorder, Muscle spasms, Neuropathy peripheral, Paraesthesia, Pneumonia, Sensory disturbance, Sleep disorder due to a general medical condition, Sputum discoloured, Tachycardia, Therapeutic product effect incomplete, Therapeutic response shortened, Wheezing, Chest discomfort, Dyspnoea exertional, Reversible airways obstruction, Weight increased, Cough, |
||||
DEXLANSOPRAZOLE, THEOPHYLLINE, THEOPHYLLINE ANHYDROUS, BUDESONIDE, ROFLUMILAST, METRONIDAZOLE, METRONIDAZOLE TOPICAL, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PREDNISONE, ALBUTEROL SULFATE, BENRALIZUMAB, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, BUPRENORPHINE, GABAPENTIN ENACARBIL, KETOCONAZOLE, KETOCONAZOLE FOAM, KETOCONAZOLE CREAM, 2%, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MOMETASONE FUROATE, MOMETASONE, MONTELUKAST, MONTELUKAST, MOXIFLOXACIN HYDROCHLORIDE, MEPOLIZUMAB, MEPOLIZUMAB, OMALIZUMAB, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, MONTELUKAST SODIUM, MONTELUKAST, MONTELUKAST SODIUM, MONTELUKAST, PREGABALIN, TIOTROPIUM BROMIDE, GLYCOPYRROLATE, MONTELUKAST SODIUM, DUPILUMAB, CEPHALEXIN, CALCIUM CARBONATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, |
||||
| 480 | 26541584 |
US |
73 | 2 |
Drug ineffective, Dyspnoea, Dizziness, |
||||
ACOLTREMON, |
||||
| 481 | 26541720 |
US |
87 | 2 |
Eye pain, Dyspnoea, |
||||
ACOLTREMON, |
||||
| 482 | 26541840 |
JP |
7 | 1 |
Interstitial lung disease, Dyspnoea, Malaise, |
||||
SACUBITRIL AND VALSARTAN, VIBEGRON, |
||||
| 483 | 26541863 |
JP |
80 | 2 |
Leukaemia, Dyspnoea, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, MACITENTAN, CLOPIDOGREL, CLOPIDOGREL BISULFATE, ANASTROZOLE, ANASTROZOLE TABLETS, |
||||
| 484 | 26541897 |
CA |
83 | 2 |
Anion gap increased, Blood glucose increased, Hyperglycaemia, Right ventricular dilatation, Shock, Fatigue, Dyspnoea, |
||||
FULVESTRANT, CAPIVASERTIB, ERGOCALCIFEROL, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, APIXABAN, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, METOPROLOL TARTRATE, METOPROLOL, ROSUVASTATIN, |
||||
| 485 | 26541918 |
GB |
54 | 1 |
Brain fog, Neuropathy peripheral, Fatigue, Dyspnoea, Dry skin, |
||||
DENOSUMAB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, BEVACIZUMAB, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, OXALIPLATIN, |
||||
| 486 | 26543688 |
46 | 1 | |
Dyspnoea, Palpitations, Weight decreased, Dehydration, Renal pain, Vomiting, |
||||
DASATINIB, |
||||
| 487 | 26552091 |
30 | 2 | |
Tachycardia, Dyspnoea, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 488 | 26554304 |
76 | 2 | |
Rash, Palpitations, Insomnia, Hypotension, Dyspnoea, Oedema, |
||||
BRIMONIDINE, BRIMONIDINE TARTRATE, CARVEDILOL, AMLODIPINE, |
||||
| 489 | 26531274 |
US |
71 | 2 |
Dyspnoea, Cough, Arthralgia, |
||||
MEPOLIZUMAB, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, |
||||
| 490 | 26531334 |
US |
63 | 2 |
Alopecia, Haemorrhage, Application site reaction, Dyspnoea, Drug ineffective, Depression, Erythema, Headache, Dyspnoea exertional, Hepatic enzyme increased, Inappropriate schedule of product administration, Incorrect dose administered, Insomnia, Intervertebral disc protrusion, Malaise, Muscular weakness, Pain, Paraesthesia, Primary biliary cholangitis, Product dose omission issue, Pruritus, Scratch, Skin burning sensation, Skin lesion, Skin plaque, Spinal meningeal cyst, Stress, Wrong technique in product usage process, Tachycardia, |
||||
OMALIZUMAB, |
||||
| 491 | 26531373 |
US |
59 | |
Drug dose omission by device, Dyspnoea, Wrong technique in product usage process, Off label use, |
||||
ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE, |
||||
| 492 | 26531507 |
CN |
||
Acute respiratory failure, Dyspnoea, Cough, |
||||
GUSELKUMAB, |
||||
| 493 | 26531604 |
US |
74 | |
Dyspnoea, Chronic obstructive pulmonary disease, Product delivery mechanism issue, Product dose omission issue, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
| 494 | 26531717 |
US |
2 | |
Dyspnoea, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, ARTIFICIAL TEARS, LUBRICANT EYE DROPS, POLYVINYL ALCOHOL, POVIDONE, GLYCERIN, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, FOLIC ACID, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, TIOTROPIUM BROMIDE, BUMETANIDE, MICONAZOLE NITRATE, AZELASTINE HYDROCHLORIDE, AZELASTINE, AMMONIUM LACTATE, METHOTREXATE, METHOTREXATE SODIUM, SPIRONOLACTONE, OXYGEN, 0XYGEN, ALBUTEROL SULFATE, GABAPENTIN, CETIRIZINE HYDROCHLORIDE, |
||||
| 495 | 26531753 |
EU |
76 | 1 |
Dyspnoea, Urinary retention, |
||||
OSIMERTINIB, |
||||
| 496 | 26531916 |
US |
||
Dyspnoea, Heart rate irregular, |
||||
NIPOCALIMAB, |
||||
| 497 | 26531969 |
GB |
||
Chest discomfort, Myopathy, Muscle spasms, Dyspnoea, |
||||
AMLODIPINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, LANSOPRAZOLE, TIOTROPIUM BROMIDE, |
||||
| 498 | 26532037 |
EU |
75 | 1 |
Respiratory disorder, Dyspnoea, Lung disorder, Dehydration, |
||||
FOSCARBIDOPA/FOSLEVODOPA, |
||||
| 499 | 26532209 |
TH |
92 | 2 |
Dyspnoea, Hypoaesthesia, Arthralgia, Infection, |
||||
DENOSUMAB, |
||||
| 500 | 26532388 |
GB |
67 | 2 |
Chest discomfort, Myopathy, Muscle spasms, Dyspnoea, |
||||
AMLODIPINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, LANSOPRAZOLE, TIOTROPIUM BROMIDE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-04-28
